Skip to content

Clinical trials

Hepatic Encephalopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatic Encephalopathy Country / region: United States Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20051
20061
20074
20081
20093
20112
20124
20137
20142
20152
20162
20173
20185
20195
20203
20216
20226
20231
20241
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated11
Withdrawn6
Active, not recruiting5
Not yet recruiting4
Recruiting3
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hunter Holmes Mcguire Veteran Affairs Medical Center8
Bausch Health Americas, Inc.5
NYU Langone Health5
University of Michigan5
Amgen2
Mayo Clinic2
Ocera Therapeutics2
University of Pittsburgh2
University of Texas Southwestern Medical Center2
VA Office of Research and Development2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatic Encephalopathy68
Fibrosis34
Liver Cirrhosis14
Liver Diseases11
Ascites7
Brain Diseases6
Hypertension, Portal6
Liver Failure6
Hepatic Insufficiency4
Liver Failure, Acute4

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.